5 Best Biotech Stocks to Buy Under $20

2. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Number of Hedge Fund Investors in Q4 2022: 39

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) develops treatments for a variety of different cancers such as cervical cancer, melanoma, and non small cell lung cancer. The company is headquartered in San Carlos, California.

After the collapse of Silicon Valley Bank earlier this month, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) assuaged investor concerns and confirmed in a regulatory filing that it does not hold deposits or securities at the defunct bank. 39 of the 943 hedge funds polled by Insider Monkey had invested in the company during Q4 2022.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)’s largest hedge fund investor in our database is Mark Rachesky’s MHR Fund Management which owns 11.9 million shares that are worth $76 million.

Follow Iovance Biotherapeutics Inc. (NASDAQ:IOVA)